Data from EPG Health Media - Curated by Toby Galbraith - Last updated 20 November 2017

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Rituzena (Rituximab)

ATC
Orphan drug
No

Updated 1 month ago

Blitzima (Rituximab)

ATC
Orphan drug
No

Updated 23 days ago

Ritemvia (Rituximab)

ATC
Orphan drug
No

Updated 25 days ago

Rixathon▼ (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago

Riximyo▼ (Rituximab)

ATC
Orphan drug
No

Updated 3 months ago

Dinutuximab beta EUSA▼ (Dinutuximab beta)

ATC
Orphan drug
Yes

Updated 26 days ago

Truxima▼ (Rituximab)

ATC
Orphan drug
No

Updated 24 days ago

Unituxin (Dinutuximab)

ATC
Orphan drug
Yes

Updated 6 months ago

Gazyvaro▼ (Obinutuzumab)

ATC
Orphan drug
Yes

Updated 4 months ago

Kadcyla▼ (Trastuzumab Emtansine)

ATC
Orphan drug
No

Updated 3 months ago